156 related articles for article (PubMed ID: 6353660)
1. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
Aamodt T; Lien JT; Haaversen O; Osmundsen K
Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
[No Abstract] [Full Text] [Related]
2. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy with sustained-release theophylline.
Myhre KI; Arnulf V; Walstad RA
Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
[TBL] [Abstract][Full Text] [Related]
4. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison of a microcrystalline theophylline tablet and salbutamol in reversible airways obstruction.
Tedders JG; Thomas AK; Edwards G
Br J Clin Pract; 1976; 30(11-12):212-6. PubMed ID: 795447
[No Abstract] [Full Text] [Related]
6. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
Dasta J; Mirtallo JM; Altman M
Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
[No Abstract] [Full Text] [Related]
7. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
Giosue S; Bernocchi D; Parola D; Munno R; Mancini P
J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318
[TBL] [Abstract][Full Text] [Related]
8. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
Lal S; Bhalla KK; Davey AJ
Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
[No Abstract] [Full Text] [Related]
9. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
Harder S; Staib AH; Stauder J
Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
[No Abstract] [Full Text] [Related]
10. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo.
Verstraeten JM
Acta Tuberc Pneumol Belg; 1979; 70(1):71-80. PubMed ID: 398153
[No Abstract] [Full Text] [Related]
11. [Theophylline treatment of irreversible, chronic obstructive pulmonary disease].
Iversen ET; Eiken PA; Nielsen LM; Laursen LC; Maltbaek N; Tønnesen FV; Rasmussen FV
Ugeskr Laeger; 1994 Sep; 156(39):5696-9. PubMed ID: 7985256
[TBL] [Abstract][Full Text] [Related]
12. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
Dorow P; Weiss T
Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
[TBL] [Abstract][Full Text] [Related]
13. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
Baronti A; Verdiani P; Di Carlo S
Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
[No Abstract] [Full Text] [Related]
14. Clinical results obtained from a new controlled release theophylline preparation.
Nolte D
Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
[No Abstract] [Full Text] [Related]
15. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease.
Gimeno F; Steenhuis EJ; Jonkman JH
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):139-43. PubMed ID: 2187001
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
Grassi V; Nicora M; Beretta A
Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
[TBL] [Abstract][Full Text] [Related]
17. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
Riddington CJ; Shipman AJ
Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
[No Abstract] [Full Text] [Related]
18. Theophylline and diaphragmatic contractility. Investigation of a dose-response relationship.
Foxworth JW; Reisz GR; Knudson SM; Cuddy PG; Pyszczynski DR; Emory CE
Am Rev Respir Dis; 1988 Dec; 138(6):1532-4. PubMed ID: 3059899
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
Kaik G
Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
[TBL] [Abstract][Full Text] [Related]
20. Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.
Thompson PJ; Kemp MW; McAllister WA; Turner-Warwick M
Br J Dis Chest; 1983 Jul; 77(3):293-8. PubMed ID: 6351891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
